Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-14, Stock:NVS, The news for the past five days is as follows:
2018-08-07: NEWS1: This Midcap Biotech Popped Nearly 20% On Hope In Cancer, Inflammation.NEWS2: Examining Pfizer’s Performance by Segment in Q2 2018.NEWS3: Ligand (LGND) Beats on Q2 Earnings & Revenues, Raises View.NEWS4: Ligand (LGND) Beats on Q2 Earnings & Revenues, Raises View.NEWS5: Teva’s Granix Gets FDA Approval for Expanded Indication.NEWS6: The Swiss Stock Market Climbed As Trade Concerns Relax.NEWS7: The Swiss Stock Market Climbed As Trade Concerns Relax.NEWS8: Mylan Stock Trending Higher before Its Q2 2018 Results.
2018-08-08: NEWS1: 3 Unloved High-Yielders That Will Rise With Rates (and Pay Up to 7% in Cash!).NEWS2: 3 Unloved High-Yielders That Will Rise With Rates (and Pay Up to 7% in Cash!).NEWS3: How Jazz Pharmaceuticals’ Products Performed in the Second Quarter.NEWS4: New Novan incentive plan targets share price goals and $25M, $50M bonus pools.NEWS5: These Products Contributed to Pfizer’s Growth in Q2 2018.NEWS6: Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract.NEWS7: The Swiss Stock Market Pulled Back On Roche Weakness.NEWS8: The Swiss Stock Market Pulled Back On Roche Weakness.
2018-08-09: NEWS1: Cabozantinib Expected to Be Exelixis’s Long-Term Growth Driver.NEWS2: The Swiss Stock Market Pulled Back As Defensive Heavyweights Fall.NEWS3: The Swiss Stock Market Pulled Back As Defensive Heavyweights Fall.
2018-08-10: NEWS1: The Swiss Stock Market Sank On Concerns Over Turkey.NEWS2: The Swiss Stock Market Sank On Concerns Over Turkey.
2018-08-13: NEWS1: Momenta Moves Meticulously.NEWS2: Momenta Moves Meticulously.NEWS3: OPKO Health Expects Its Loss per Share to Shrink This Year.NEWS4: Mixed Reviews For Allakos As Sell-Side Starts Coverage Of Biotech.NEWS5: OPKO Health’s Q3 2018 Revenue Expectations.NEWS6: How GlaxoSmithKline’s Segments Have Performed.NEWS7: Analyzing GlaxoSmithKline’s Revenue Trends.NEWS8: Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings.NEWS9: Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings.NEWS10: Roche's (RHHBY) Xolair Gets Breakthrough Therapy Status.NEWS11: Roche's (RHHBY) Xolair Gets Breakthrough Therapy Status.NEWS12: Novo Nordisk: A Financial Overview after the First Half of 2018.NEWS13: Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now?.NEWS14: Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now?.NEWS15: The Swiss Stock Market Pared Its Losses In Late Trade.NEWS16: The Swiss Stock Market Pared Its Losses In Late Trade.

Answer: Decrease